The global Disease Risk and Health Test market size was valued at USD 390 million in 2023 and is forecast to a readjusted size of USD 1120.2 million by 2030 with a CAGR of 16.3% during review period.
The results of these tests estimate your genetic risk of developing several common diseases, such as听celiac disease,听Parkinson disease, and听Alzheimer disease. Some companies also include a person鈥檚 carrier status for less common conditions, including听cystic fibrosis听and听sickle cell disease. A carrier is someone who has one copy of a gene mutation that, when present in two copies, causes a genetic disorder.
The Direct-to-Consumer Genetic Testing 麻豆原创 is driven by the increasing consumer interest in understanding their genetic heritage, health risks, and ancestry. These tests provide individuals with accessible insights into their DNA, empowering them to make informed decisions about their health and heritage. Additionally, the ease of ordering these tests online and receiving results at home has made genetic testing more convenient and popular. However, a key challenge for this market is the need to address privacy and security concerns related to sensitive genetic data. Ensuring that consumer data is protected and not misused is a critical challenge. Furthermore, interpreting complex genetic information accurately can be a hurdle, as consumers may not fully understand the results or the potential implications. Striking a balance between accessibility and providing comprehensive education and genetic counseling is essential for the responsible growth of the Direct-to-Consumer Genetic Testing 麻豆原创.
This report includes an overview of the development of the Disease Risk and Health Test industry chain, the market status of Online (Celiac Disease, Parkinson Disease), Offline (Celiac Disease, Parkinson Disease), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Disease Risk and Health Test.
Regionally, the report analyzes the Disease Risk and Health Test markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Disease Risk and Health Test market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Disease Risk and Health Test market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Disease Risk and Health Test industry.
The report involves analyzing the market at a macro level:
麻豆原创 Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Celiac Disease, Parkinson Disease).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Disease Risk and Health Test market.
Regional Analysis: The report involves examining the Disease Risk and Health Test market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
麻豆原创 Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Disease Risk and Health Test market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Disease Risk and Health Test:
Company Analysis: Report covers individual Disease Risk and Health Test players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Disease Risk and Health Test This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Online, Offline).
Technology Analysis: Report covers specific technologies relevant to Disease Risk and Health Test. It assesses the current state, advancements, and potential future developments in Disease Risk and Health Test areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Disease Risk and Health Test market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
麻豆原创 Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
麻豆原创 Segmentation
Disease Risk and Health Test market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
麻豆原创 segment by Type
Celiac Disease
Parkinson Disease
Alzheimer Disease
Other
麻豆原创 segment by Application
Online
Offline
麻豆原创 segment by players, this report covers
23andMe
MyHeritage
LabCorp
Myriad Genetics
Ancestry
Quest Diagnostics
Gene By Gene
DNA Diagnostics Center
Invitae
IntelliGenetics
Ambry Genetics
Living DNA
EasyDNA
Pathway Genomics
Centrillion Technology
Xcode
Color Genomics
Anglia DNA Services
African Ancestry
Canadian DNA Services
DNA Family Check
Alpha Biolaboratories
Test Me DNA
23 Mofang
Genetic Health
DNA Services of America
Shuwen Health Sciences
Mapmygenome
Full Genomes
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Disease Risk and Health Test product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Disease Risk and Health Test, with revenue, gross margin and global market share of Disease Risk and Health Test from 2019 to 2024.
Chapter 3, the Disease Risk and Health Test competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Disease Risk and Health Test market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Disease Risk and Health Test.
Chapter 13, to describe Disease Risk and Health Test research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope of Disease Risk and Health Test
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Disease Risk and Health Test by Type
1.3.1 Overview: Global Disease Risk and Health Test 麻豆原创 Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Disease Risk and Health Test Consumption Value 麻豆原创 Share by Type in 2023
1.3.3 Celiac Disease
1.3.4 Parkinson Disease
1.3.5 Alzheimer Disease
1.3.6 Other
1.4 Global Disease Risk and Health Test 麻豆原创 by Application
1.4.1 Overview: Global Disease Risk and Health Test 麻豆原创 Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Online
1.4.3 Offline
1.5 Global Disease Risk and Health Test 麻豆原创 Size & Forecast
1.6 Global Disease Risk and Health Test 麻豆原创 Size and Forecast by Region
1.6.1 Global Disease Risk and Health Test 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Disease Risk and Health Test 麻豆原创 Size by Region, (2019-2030)
1.6.3 North America Disease Risk and Health Test 麻豆原创 Size and Prospect (2019-2030)
1.6.4 Europe Disease Risk and Health Test 麻豆原创 Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Disease Risk and Health Test 麻豆原创 Size and Prospect (2019-2030)
1.6.6 South America Disease Risk and Health Test 麻豆原创 Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Disease Risk and Health Test 麻豆原创 Size and Prospect (2019-2030)
2 Company Profiles
2.1 23andMe
2.1.1 23andMe Details
2.1.2 23andMe Major Business
2.1.3 23andMe Disease Risk and Health Test Product and Solutions
2.1.4 23andMe Disease Risk and Health Test Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 23andMe Recent Developments and Future Plans
2.2 MyHeritage
2.2.1 MyHeritage Details
2.2.2 MyHeritage Major Business
2.2.3 MyHeritage Disease Risk and Health Test Product and Solutions
2.2.4 MyHeritage Disease Risk and Health Test Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 MyHeritage Recent Developments and Future Plans
2.3 LabCorp
2.3.1 LabCorp Details
2.3.2 LabCorp Major Business
2.3.3 LabCorp Disease Risk and Health Test Product and Solutions
2.3.4 LabCorp Disease Risk and Health Test Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 LabCorp Recent Developments and Future Plans
2.4 Myriad Genetics
2.4.1 Myriad Genetics Details
2.4.2 Myriad Genetics Major Business
2.4.3 Myriad Genetics Disease Risk and Health Test Product and Solutions
2.4.4 Myriad Genetics Disease Risk and Health Test Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Myriad Genetics Recent Developments and Future Plans
2.5 Ancestry
2.5.1 Ancestry Details
2.5.2 Ancestry Major Business
2.5.3 Ancestry Disease Risk and Health Test Product and Solutions
2.5.4 Ancestry Disease Risk and Health Test Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 Ancestry Recent Developments and Future Plans
2.6 Quest Diagnostics
2.6.1 Quest Diagnostics Details
2.6.2 Quest Diagnostics Major Business
2.6.3 Quest Diagnostics Disease Risk and Health Test Product and Solutions
2.6.4 Quest Diagnostics Disease Risk and Health Test Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 Quest Diagnostics Recent Developments and Future Plans
2.7 Gene By Gene
2.7.1 Gene By Gene Details
2.7.2 Gene By Gene Major Business
2.7.3 Gene By Gene Disease Risk and Health Test Product and Solutions
2.7.4 Gene By Gene Disease Risk and Health Test Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 Gene By Gene Recent Developments and Future Plans
2.8 DNA Diagnostics Center
2.8.1 DNA Diagnostics Center Details
2.8.2 DNA Diagnostics Center Major Business
2.8.3 DNA Diagnostics Center Disease Risk and Health Test Product and Solutions
2.8.4 DNA Diagnostics Center Disease Risk and Health Test Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.8.5 DNA Diagnostics Center Recent Developments and Future Plans
2.9 Invitae
2.9.1 Invitae Details
2.9.2 Invitae Major Business
2.9.3 Invitae Disease Risk and Health Test Product and Solutions
2.9.4 Invitae Disease Risk and Health Test Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.9.5 Invitae Recent Developments and Future Plans
2.10 IntelliGenetics
2.10.1 IntelliGenetics Details
2.10.2 IntelliGenetics Major Business
2.10.3 IntelliGenetics Disease Risk and Health Test Product and Solutions
2.10.4 IntelliGenetics Disease Risk and Health Test Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.10.5 IntelliGenetics Recent Developments and Future Plans
2.11 Ambry Genetics
2.11.1 Ambry Genetics Details
2.11.2 Ambry Genetics Major Business
2.11.3 Ambry Genetics Disease Risk and Health Test Product and Solutions
2.11.4 Ambry Genetics Disease Risk and Health Test Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.11.5 Ambry Genetics Recent Developments and Future Plans
2.12 Living DNA
2.12.1 Living DNA Details
2.12.2 Living DNA Major Business
2.12.3 Living DNA Disease Risk and Health Test Product and Solutions
2.12.4 Living DNA Disease Risk and Health Test Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.12.5 Living DNA Recent Developments and Future Plans
2.13 EasyDNA
2.13.1 EasyDNA Details
2.13.2 EasyDNA Major Business
2.13.3 EasyDNA Disease Risk and Health Test Product and Solutions
2.13.4 EasyDNA Disease Risk and Health Test Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.13.5 EasyDNA Recent Developments and Future Plans
2.14 Pathway Genomics
2.14.1 Pathway Genomics Details
2.14.2 Pathway Genomics Major Business
2.14.3 Pathway Genomics Disease Risk and Health Test Product and Solutions
2.14.4 Pathway Genomics Disease Risk and Health Test Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.14.5 Pathway Genomics Recent Developments and Future Plans
2.15 Centrillion Technology
2.15.1 Centrillion Technology Details
2.15.2 Centrillion Technology Major Business
2.15.3 Centrillion Technology Disease Risk and Health Test Product and Solutions
2.15.4 Centrillion Technology Disease Risk and Health Test Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.15.5 Centrillion Technology Recent Developments and Future Plans
2.16 Xcode
2.16.1 Xcode Details
2.16.2 Xcode Major Business
2.16.3 Xcode Disease Risk and Health Test Product and Solutions
2.16.4 Xcode Disease Risk and Health Test Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.16.5 Xcode Recent Developments and Future Plans
2.17 Color Genomics
2.17.1 Color Genomics Details
2.17.2 Color Genomics Major Business
2.17.3 Color Genomics Disease Risk and Health Test Product and Solutions
2.17.4 Color Genomics Disease Risk and Health Test Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.17.5 Color Genomics Recent Developments and Future Plans
2.18 Anglia DNA Services
2.18.1 Anglia DNA Services Details
2.18.2 Anglia DNA Services Major Business
2.18.3 Anglia DNA Services Disease Risk and Health Test Product and Solutions
2.18.4 Anglia DNA Services Disease Risk and Health Test Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.18.5 Anglia DNA Services Recent Developments and Future Plans
2.19 African Ancestry
2.19.1 African Ancestry Details
2.19.2 African Ancestry Major Business
2.19.3 African Ancestry Disease Risk and Health Test Product and Solutions
2.19.4 African Ancestry Disease Risk and Health Test Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.19.5 African Ancestry Recent Developments and Future Plans
2.20 Canadian DNA Services
2.20.1 Canadian DNA Services Details
2.20.2 Canadian DNA Services Major Business
2.20.3 Canadian DNA Services Disease Risk and Health Test Product and Solutions
2.20.4 Canadian DNA Services Disease Risk and Health Test Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.20.5 Canadian DNA Services Recent Developments and Future Plans
2.21 DNA Family Check
2.21.1 DNA Family Check Details
2.21.2 DNA Family Check Major Business
2.21.3 DNA Family Check Disease Risk and Health Test Product and Solutions
2.21.4 DNA Family Check Disease Risk and Health Test Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.21.5 DNA Family Check Recent Developments and Future Plans
2.22 Alpha Biolaboratories
2.22.1 Alpha Biolaboratories Details
2.22.2 Alpha Biolaboratories Major Business
2.22.3 Alpha Biolaboratories Disease Risk and Health Test Product and Solutions
2.22.4 Alpha Biolaboratories Disease Risk and Health Test Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.22.5 Alpha Biolaboratories Recent Developments and Future Plans
2.23 Test Me DNA
2.23.1 Test Me DNA Details
2.23.2 Test Me DNA Major Business
2.23.3 Test Me DNA Disease Risk and Health Test Product and Solutions
2.23.4 Test Me DNA Disease Risk and Health Test Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.23.5 Test Me DNA Recent Developments and Future Plans
2.24 23 Mofang
2.24.1 23 Mofang Details
2.24.2 23 Mofang Major Business
2.24.3 23 Mofang Disease Risk and Health Test Product and Solutions
2.24.4 23 Mofang Disease Risk and Health Test Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.24.5 23 Mofang Recent Developments and Future Plans
2.25 Genetic Health
2.25.1 Genetic Health Details
2.25.2 Genetic Health Major Business
2.25.3 Genetic Health Disease Risk and Health Test Product and Solutions
2.25.4 Genetic Health Disease Risk and Health Test Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.25.5 Genetic Health Recent Developments and Future Plans
2.26 DNA Services of America
2.26.1 DNA Services of America Details
2.26.2 DNA Services of America Major Business
2.26.3 DNA Services of America Disease Risk and Health Test Product and Solutions
2.26.4 DNA Services of America Disease Risk and Health Test Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.26.5 DNA Services of America Recent Developments and Future Plans
2.27 Shuwen Health Sciences
2.27.1 Shuwen Health Sciences Details
2.27.2 Shuwen Health Sciences Major Business
2.27.3 Shuwen Health Sciences Disease Risk and Health Test Product and Solutions
2.27.4 Shuwen Health Sciences Disease Risk and Health Test Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.27.5 Shuwen Health Sciences Recent Developments and Future Plans
2.28 Mapmygenome
2.28.1 Mapmygenome Details
2.28.2 Mapmygenome Major Business
2.28.3 Mapmygenome Disease Risk and Health Test Product and Solutions
2.28.4 Mapmygenome Disease Risk and Health Test Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.28.5 Mapmygenome Recent Developments and Future Plans
2.29 Full Genomes
2.29.1 Full Genomes Details
2.29.2 Full Genomes Major Business
2.29.3 Full Genomes Disease Risk and Health Test Product and Solutions
2.29.4 Full Genomes Disease Risk and Health Test Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.29.5 Full Genomes Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Disease Risk and Health Test Revenue and Share by Players (2019-2024)
3.2 麻豆原创 Share Analysis (2023)
3.2.1 麻豆原创 Share of Disease Risk and Health Test by Company Revenue
3.2.2 Top 3 Disease Risk and Health Test Players 麻豆原创 Share in 2023
3.2.3 Top 6 Disease Risk and Health Test Players 麻豆原创 Share in 2023
3.3 Disease Risk and Health Test 麻豆原创: Overall Company Footprint Analysis
3.3.1 Disease Risk and Health Test 麻豆原创: Region Footprint
3.3.2 Disease Risk and Health Test 麻豆原创: Company Product Type Footprint
3.3.3 Disease Risk and Health Test 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Disease Risk and Health Test Consumption Value and 麻豆原创 Share by Type (2019-2024)
4.2 Global Disease Risk and Health Test 麻豆原创 Forecast by Type (2025-2030)
5 麻豆原创 Size Segment by Application
5.1 Global Disease Risk and Health Test Consumption Value 麻豆原创 Share by Application (2019-2024)
5.2 Global Disease Risk and Health Test 麻豆原创 Forecast by Application (2025-2030)
6 North America
6.1 North America Disease Risk and Health Test Consumption Value by Type (2019-2030)
6.2 North America Disease Risk and Health Test Consumption Value by Application (2019-2030)
6.3 North America Disease Risk and Health Test 麻豆原创 Size by Country
6.3.1 North America Disease Risk and Health Test Consumption Value by Country (2019-2030)
6.3.2 United States Disease Risk and Health Test 麻豆原创 Size and Forecast (2019-2030)
6.3.3 Canada Disease Risk and Health Test 麻豆原创 Size and Forecast (2019-2030)
6.3.4 Mexico Disease Risk and Health Test 麻豆原创 Size and Forecast (2019-2030)
7 Europe
7.1 Europe Disease Risk and Health Test Consumption Value by Type (2019-2030)
7.2 Europe Disease Risk and Health Test Consumption Value by Application (2019-2030)
7.3 Europe Disease Risk and Health Test 麻豆原创 Size by Country
7.3.1 Europe Disease Risk and Health Test Consumption Value by Country (2019-2030)
7.3.2 Germany Disease Risk and Health Test 麻豆原创 Size and Forecast (2019-2030)
7.3.3 France Disease Risk and Health Test 麻豆原创 Size and Forecast (2019-2030)
7.3.4 United Kingdom Disease Risk and Health Test 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Russia Disease Risk and Health Test 麻豆原创 Size and Forecast (2019-2030)
7.3.6 Italy Disease Risk and Health Test 麻豆原创 Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Disease Risk and Health Test Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Disease Risk and Health Test Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Disease Risk and Health Test 麻豆原创 Size by Region
8.3.1 Asia-Pacific Disease Risk and Health Test Consumption Value by Region (2019-2030)
8.3.2 China Disease Risk and Health Test 麻豆原创 Size and Forecast (2019-2030)
8.3.3 Japan Disease Risk and Health Test 麻豆原创 Size and Forecast (2019-2030)
8.3.4 South Korea Disease Risk and Health Test 麻豆原创 Size and Forecast (2019-2030)
8.3.5 India Disease Risk and Health Test 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Southeast Asia Disease Risk and Health Test 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Australia Disease Risk and Health Test 麻豆原创 Size and Forecast (2019-2030)
9 South America
9.1 South America Disease Risk and Health Test Consumption Value by Type (2019-2030)
9.2 South America Disease Risk and Health Test Consumption Value by Application (2019-2030)
9.3 South America Disease Risk and Health Test 麻豆原创 Size by Country
9.3.1 South America Disease Risk and Health Test Consumption Value by Country (2019-2030)
9.3.2 Brazil Disease Risk and Health Test 麻豆原创 Size and Forecast (2019-2030)
9.3.3 Argentina Disease Risk and Health Test 麻豆原创 Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Disease Risk and Health Test Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Disease Risk and Health Test Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Disease Risk and Health Test 麻豆原创 Size by Country
10.3.1 Middle East & Africa Disease Risk and Health Test Consumption Value by Country (2019-2030)
10.3.2 Turkey Disease Risk and Health Test 麻豆原创 Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Disease Risk and Health Test 麻豆原创 Size and Forecast (2019-2030)
10.3.4 UAE Disease Risk and Health Test 麻豆原创 Size and Forecast (2019-2030)
11 麻豆原创 Dynamics
11.1 Disease Risk and Health Test 麻豆原创 Drivers
11.2 Disease Risk and Health Test 麻豆原创 Restraints
11.3 Disease Risk and Health Test Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Disease Risk and Health Test Industry Chain
12.2 Disease Risk and Health Test Upstream Analysis
12.3 Disease Risk and Health Test Midstream Analysis
12.4 Disease Risk and Health Test Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
23andMe
MyHeritage
LabCorp
Myriad Genetics
Ancestry
Quest Diagnostics
Gene By Gene
DNA Diagnostics Center
Invitae
IntelliGenetics
Ambry Genetics
Living DNA
EasyDNA
Pathway Genomics
Centrillion Technology
Xcode
Color Genomics
Anglia DNA Services
African Ancestry
Canadian DNA Services
DNA Family Check
Alpha Biolaboratories
Test Me DNA
23 Mofang
Genetic Health
DNA Services of America
Shuwen Health Sciences
Mapmygenome
Full Genomes
听
听
*If Applicable.
